Odicon 150 Tablet contains Fluconazole 150 mg, an antifungal agent belonging to the triazole class, used primarily for the treatment and prevention of a variety of fungal infections. Fluconazole works by inhibiting the fungal cytochrome P450 enzyme 14α-demethylase, which is essential for converting lanosterol to ergosterol, a critical component of the fungal cell membrane. This inhibition leads to increased membrane permeability and ultimately fungal cell death. Odicon 150 is commonly prescribed for infections caused by Candida species, including oropharyngeal, esophageal, and systemic candidiasis, as well as cryptococcal meningitis. It is also effective against dermatophytic infections and certain other fungal pathogens. The tablet is administered orally, with dosing adjusted based on the type and severity of infection, patient age, and renal function. Fluconazole is well absorbed with high bioavailability and penetrates well into body fluids including cerebrospinal fluid. Common side effects include headache, nausea, abdominal pain, and rash, though serious adverse reactions are rare. Caution is advised in patients with liver impairment or those taking medications that may interact with fluconazole. Odicon 150 should be used under medical supervision to ensure appropriate use and monitoring.